Stock listing

NGM:LEVBIO Level Bio AB Aktie

Home listing (NGM) of Level Bio AB

Follow Level Bio AB into a list and get an email when it puts out news.

Level Bio AB logo
Ticker
NGM:LEVBIO
Asset type
Stock
Exchange
NGM
Currency
SEK

What changed lately

Latest news

LEVBIO: 15% sales growth and CyberGene divestment signal a strategic focus on diagnostics distribution

Apr 23, 2026

LEVBIO: 29% sales growth and improved results, but future revenue to decline after CyberGene sale

Feb 19, 2026

LEVBIO: Q3 2025 saw 5% revenue growth, higher margins, and improved cash flow amid Nordic expansion

Oct 23, 2025

LEVBIO: Platform upgrades, Q4 pilot, and lab partnerships drive ongoing business development

Aug 21, 2025

LEVBIO: Nordic market growth surged 44% year-over-year, fueled by rebranding and tech advances

Apr 24, 2025

LEVBIO: Improved margins and reduced losses signal a turnaround, but liquidity remains a key risk

Feb 20, 2025

LEVBIO: Flat sales but improved results and cash flow signal operational progress and future growth

Oct 24, 2024

LEVBIO: Q2 sales grew 10% year-over-year, with H2 growth expected from new products

Aug 22, 2024

All Level Bio AB news

Level Bio AB on 6ix

News releases
3 in the last 12 months · 8 in all · newest Apr 23, 2026 · oldest 2024

Where Level Bio AB is listed

ListingExchangeCountryCurrency
NGM:LEVBIO · Home listing · This pageNGMSwedenSEK
Frankfurt:4MBFrankfurtGermanyEUR

Log in to ask 6ix AI your own questions about Level Bio AB.